Grant · Cancer Biology
Fully-funded PhD studentship: Unmasking mechanisms of resistance to KRAS inhibition across pancreatic cancer genetic profiles
University of Cambridge
Closes tomorrow
Investigate resistance to KRAS inhibition across genetically distinct pancreatic cancers. The doctoral project studies tumour-cell and stromal mechanisms, including fibroblast effects, using organoid transplantation, mouse models, CRISPR, single-cell sequencing, flow cytometry and spatial methods. It seeks evidence for rational combination therapies and begins in October 2027.